Studying the relationship between autism spectrum disorder and cancer in individuals affected by PTEN hamartoma tumor syndrome is the subject of a new $2 million grant awarded from the National Institutes of Health to Charis Eng, MD, PhD, Chair of the Genomic Medicine Institute.Read More
Cleveland Clinic Unveils Top 10 Medical Innovations For 2016
Cleveland Clinic physicians and scientists release annual Top 10 innovations list, including faster methods of creating vaccines, a process for rewriting genetic code and a water purification system for the developing world.
The New Way to Train Future Doctors
In just the past decade or two, healthcare has undergone tremendous change. We don’t expect it to let up. The change will continue, and it has forced us to rethink the way that we educate the next generation of doctors.
Genomics-Driven Clinical Trials Scarce in Cancer Therapy
Precision medicine matches a tumor’s unique genetic information with a targeted therapeutic and can be highly effective — provided the therapy is available. Often it isn’t.
Getting Personalized: Therapeutic Targeting of Brain Tumors Gets Smarter Through Genomics
Many patients with glioblastoma or meningioma at Cleveland Clinic are now offered genomic profiling of their tumors. Here’s why, along with a glimpse of where the practice is taking brain tumor therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy